Skip to search formSkip to main contentSkip to account menu

Mitoxantrone

Known as: 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinone, 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione, Mitoxantronum 
An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Mitoxantrone is useful for the treatment of cancer and MS and, as with other chemotherapeutic agents, many studies have examined… 
2002
2002
The effect of base sequence on excess electron transfer (ET) along the DNA “π-way" is investigated in this work by use of various… 
1996
1996
SummaryWe undertook a phase I-II trial of loco-regional mitoxantrone in 12 patients affected by malignant gliomas. Mitoxantrone… 
1994
1994
The multidrug resistance (MDR) modulators amiodarone (AM), cyclosporin A (CsA), and PSC 833 were tested for their potential to… 
Highly Cited
1984
Highly Cited
1984
: Mitoxantrone has been administered to more than 4000 patients worldwide. From this data base, a summary of the latest… 
1984
1984
Mitoxantrone is a relatively new synthetic anthracenedione derivative with intercalating properties. An in vitro study with… 
1983
1983
: The effect of elevated temperature on the cytotoxicity of three new anticancer drugs (vindesine, mitoxantrone, and amsacrine… 
1982
1982
Dihydroxyanthraquinone [1,4-dihydroxy-5,8-bis ((2-([(2-hydroxyethyl)amino)ethyl)amino))-9,10-anthracenedione (DHAQ) (NSC 279836… 
1982
1982
Mitoxantrone (1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride) in animal… 
1980
1980
The effect of dihydroxyanthraquinone (DHAQ), a potential anticancer chemotherapeutic agent, on the progression of Chinese hamster…